Generics in Japan
Description
Generics in Japan
Summary
Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The Japanese generics market recorded revenues of $12.3 billion in 2024, representing a compound annual growth rate (CAGR) of 9.6% between 2019 and 2024.
- Market consumption volume increased with a CAGR of 5.0% between 2019 and 2024, reaching a total of 53.6% of total pharma volume in 2024.
- In 2024, the revenue of the Japanese generics market experienced an annual growth of 14.3%. The market’s growth is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, increasing the demand for affordable, long-term medications.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Japan
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan generics market with five year forecasts
- What was the size of the Japan generics market by value in 2024?
- What will be the size of the Japan generics market in 2029?
- What factors are affecting the strength of competition in the Japan generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's generics market?
Table of Contents
45 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strategies of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Toho Holdings Co Ltd
- 8.2. Daiichi Sankyo Co Ltd
- 8.3. Sawai Group Holdings Co Ltd
- 8.4. Towa Pharmaceutical Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Japan generics market value: $ million, 2019-24
- Table 2: Japan generics market volume: % of total pharma volume, 2019-24
- Table 3: Japan generics market geography segmentation: $ million, 2024
- Table 4: Japan generics market value forecast: $ million, 2024-29
- Table 5: Japan generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Toho Holdings Co Ltd: Key Facts
- Table 7: Toho Holdings Co Ltd: Annual Financial Ratios
- Table 8: Toho Holdings Co Ltd: Key Employees
- Table 9: Daiichi Sankyo Co Ltd: Key Facts
- Table 10: Daiichi Sankyo Co Ltd: Annual Financial Ratios
- Table 11: Daiichi Sankyo Co Ltd: Key Employees
- Table 12: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 13: Sawai Group Holdings Co Ltd: Key Facts
- Table 14: Sawai Group Holdings Co Ltd: Annual Financial Ratios
- Table 15: Sawai Group Holdings Co Ltd: Key Employees
- Table 16: Towa Pharmaceutical Co Ltd: Key Facts
- Table 17: Towa Pharmaceutical Co Ltd: Annual Financial Ratios
- Table 18: Towa Pharmaceutical Co Ltd: Key Employees
- Table 19: Towa Pharmaceutical Co Ltd: Key Employees Continued
- Table 20: Japan Size of Population (Million), 2020-24
- Table 21: Japan Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 22: Japan GDP (Current Prices, $ Billion), 2020-24
- Table 23: Japan Inflation, 2020-24
- Table 24: Japan Consumer Price Index (Absolute), 2020-24
- Table 25: Japan Exchange Rate, 2019-24
- List of Figures
- Figure 1: Japan generics market value: $ million, 2019-24
- Figure 2: Japan generics market volume: % of total pharma volume, 2019-24
- Figure 3: Japan generics market geography segmentation: % share, by value, 2024
- Figure 4: Japan generics market value forecast: $ million, 2024-29
- Figure 5: Japan generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in Japan, 2024
- Figure 7: Drivers of buyer power in the generics market in Japan, 2024
- Figure 8: Drivers of supplier power in the generics market in Japan, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Japan, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in Japan, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in Japan, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


